Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)
- Status
- RECRUITING
- Phase
- PHASE3
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
- Status
- RECRUITING
- Phase
- PHASE1
Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
- Status
- RECRUITING
- Phase
- PHASE3
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of GS-0272 in Participants With Rheumatoid Arthritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of Obeldesivir in Children and Adolescents With COVID-19
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Leveraging Chatbot to Improve PrEP in the Southern United States
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Teamwork Makes the Dream Work
- Status
- RECRUITING
- Phase
- NA